The Artificial Intelligence in Genomics Market Size is valued at 757.26 Million in 2023 and is predicted to reach 18,618.72 Million by the year 2031 at a 49.4 % CAGR during the forecast period for 2024-2031.
The Global Artificial Intelligence in Genomics market is segmented on the basis of offering, application, technology type, functionality, and region. Based on the offering, the AI in the genomics market is divided into Software, Services. Based on the application, the AI in the genomics market is divided into Diagnostics, Drug Discovery & Development, Precision Medicine, Agriculture & animal Research, Other Applications. On the basis of technology, the market is segmented into Machine Learning and Other Technologies. Machine Learning is further segmented into Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other Machine Learning Technologies.
The growing research and development activities for the development of advanced treatment to treat various diseases and the high application of machine learning and deep learning in drug development are expected to the market growth significantly in the coming years. By Functionality, the market is segmented into Genome Sequencing, Gene Editing, Clinical Workflows, and Predictive Genetic Testing & Preventive Medicine. By end-user, the market is segmented into Pharmaceutical & Biotech Companies, Healthcare Providers, Research Centers, Academic Institutes & Government Organizations, and Other End-Users. The growing adoption of AI in the large number of companies operating in drug development and research activities is expected to propel the growth AI in the genomics market significantly.
Based on the region, the market is segmented into Latin America, Asia Pacific, Middle East & Africa, North America, and Europe. In 2019, North America accounted for the largest share in AI in the genomics market, followed by Europe.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 757.26 Million |
| Revenue Forecast In 2031 | USD 18,618.72 Million |
| Growth Rate CAGR | CAGR of 49.4 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Offering, By Functionality, By Technology, By Application, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | AI Therapeutics, Inc., Ares Genetics GmbH, BenevolentAI, BioSymetrics, Cambridge Cancer Genomics (UK), Clover Therapeutics, Congenica Ltd, Coral Genomics, CureMatch, Inc., Cyclica Inc., Data4Cure, Inc, Deep Genomics, Desktop Genetics Ltd., Diploid (Belgium), DNAnexus, Emedgene, Empiric Logic, Engine Biosciences Pte. Ltd., Fabric Genomics, Inc., FDNA Inc. (US), Freenome Holdings, Inc., Genoox, Ltd., IBM (US), LifebitAI, Microsoft (Project Hanover), MolecularMatch Inc. (US), NVIDIA Corporation (US), PrecisionLife Ltd, Predictive Oncology, SOPHiA GENETICS, Inc., Trace Genomics, Verge Genomics, WhiteLab Genomics, WuXi Nextcode Genomics |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence (AI) in Genomics Market Snapshot
Chapter 4. Global Artificial Intelligence (AI) in Genomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Offering:
5.2.1. Software
5.2.2. Services
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:
6.2.1. Machine Learning
6.2.2. Deep Learning
6.2.3. Supervised Learning
6.2.4. Reinforcement Learning
6.2.5. Unsupervised Learning
6.2.6. Other Machine Learning Technologies
6.2.7. Other Technologies
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
7.2.1. Diagnostics
7.2.2. Drug Discovery & Development
7.2.3. Precision Medicine
7.2.4. Agriculture & animal Research
7.2.5. Other Applications
Chapter 8. Market Segmentation 4: By Functionality Estimates & Trend Analysis
8.1. By Functionality & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Functionality:
8.2.1. Genome Sequencing
8.2.2. Gene Editing
8.2.3. Clinical Workflows
8.2.4. Predictive Genetic Testing & Preventive Medicine
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By End User & Market Share, 2019 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:
9.2.1. Pharmaceutical & Biotech Companies
9.2.2. Healthcare Providers
9.2.3. Research Centers, Academic Institutes & Government Organizations
9.2.4. Other End-Users
Chapter 10. Artificial Intelligence (AI) in Genomics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Offering, 2024- 2031
10.1.2. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Technology, 2024- 2031
10.1.3. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Application, 2024- 2031
10.1.4. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By Functionality, 2024- 2031
10.1.5. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts By End User, 2024- 2031
10.1.6. North America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) estimates and forecasts by country, 2024- 2031
10.2. Europe
10.2.1. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, 2024- 2031
10.2.2. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, 2024- 2031
10.2.3. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, 2024- 2031
10.2.4. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, 2024- 2031
10.2.5. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, 2024- 2031
10.2.6. Europe Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.3. Asia Pacific
10.3.1. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, 2024- 2031
10.3.2. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, 2024- 2031
10.3.3. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, 2024- 2031
10.3.4. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, 2024- 2031
10.3.5. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, 2024- 2031
10.3.6. Asia Pacific Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.4. Latin America
10.4.1. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, (US$ Million) 2024- 2031
10.4.2. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2024- 2031
10.4.3. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, (US$ Million) 2024- 2031
10.4.4. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, (US$ Million) 2024- 2031
10.4.5. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, (US$ Million) 2024- 2031
10.4.6. Latin America Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Offering, (US$ Million) 2024- 2031
10.5.2. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2024- 2031
10.5.3. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Application, (US$ Million) 2024- 2031
10.5.4. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By Functionality, (US$ Million) 2024- 2031
10.5.5. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) By End User, (US$ Million) 2024- 2031
10.5.6. Middle East & Africa Artificial Intelligence (AI) in Genomics Market revenue (US$ Million) by country, 2024- 2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. AI Therapeutics, Inc.,
11.2.2. Ares Genetics GmbH,
11.2.3. BenevolentAI,
11.2.4. BioSymetrics,
11.2.5. Cambridge Cancer Genomics (UK),
11.2.6. Clover Therapeutics,
11.2.7. Congenica Ltd,
11.2.8. Coral Genomics,
11.2.9. CureMatch, Inc.,
11.2.10. Cyclica Inc.,
11.2.11. Data4Cure, Inc,
11.2.12. Deep Genomics,
11.2.13. Desktop Genetics Ltd.,
11.2.14. Diploid (Belgium),
11.2.15. DNAnexus,
11.2.16. Emedgene,
11.2.17. Empiric Logic,
11.2.18. Engine Biosciences Pte. Ltd.,
11.2.19. Fabric Genomics, Inc.,
11.2.20. FDNA Inc. (US),
11.2.21. Freenome Holdings, Inc.,
11.2.22. Genoox, Ltd.,
11.2.23. IBM (US),
11.2.24. LifebitAI,
11.2.25. Microsoft (Project Hanover),
11.2.26. MolecularMatch Inc. (US),
11.2.27. NVIDIA Corporation (US),
11.2.28. PrecisionLife Ltd,
11.2.29. Predictive Oncology,
11.2.30. SOPHiA GENETICS, Inc.,
11.2.31. Trace Genomics,
11.2.32. Verge Genomics,
11.2.33. WhiteLab Genomics,
11.2.34. WuXi Nextcode Genomics
Global Artificial Intelligence (AI) in Genomics Market by Offering
Global Artificial Intelligence (AI) in Genomics Market by Applications
Global Artificial Intelligence (AI) in Genomics Market by Technology
Global Artificial Intelligence (AI) in Genomics Market by Functionality
Global Artificial Intelligence (AI) in Genomics Market by End-Users
Global Artificial Intelligence in Genomics Market Based on Region
Europe Artificial Intelligence in Genomics Market
North America Artificial Intelligence in Genomics Market
Asia Pacific Artificial Intelligence in Genomics Market
Latin America Artificial Intelligence in Genomics Market
Middle East & Africa Artificial Intelligence in Genomics Market